Evaluation of liver function parameters by Tc-99m-GSA using multivariate analysis: A study of 47 clinical cases

Acta Medica Okayama

Volumn 53, Issue 5, 1999, Pages 225-232

  Suzuki, Yasunori ^a   Kohno, Yoshihiro ^b   Takeda, Yoshihiro ^a   Hiraki, Yoshio ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Fukuyama National Hospital   (Japan)

Author keywords

Hepatocellular carcinoma; Multivariate analysis; Technetium 99m DTPA galactosyl human serum albumin; Transcatheter arterial embolization

Indexed keywords

DIAGNOSTIC AGENT; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA GALACTOSYL HUMAN SERUM ALBUMIN; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

AGED; ARTERY; ARTICLE; ARTIFICIAL EMBOLISM; COMPARATIVE STUDY; FEMALE; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER TUMOR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; STATISTICS; VASCULARIZATION;

AGED; ARTERIES; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOPHARMACEUTICALS; STATISTICS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 0033210420     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ashwell G and Steer CJ: Hepatic recognition and catabolism of serum gylcoproteins. JAMA (1981) 246, 2358-2364.
2. Stockert RJ and Morell AG: Hepatic binding protein: The galactose-specific receptor of mammalian hepatocytes. Hepatology (1983) 3, 750-757.
3. Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y and Tashiro Y: Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Gastroenterology (1984) 87, 1217-1221.
4. 99mTc-GSA, a new agent for functional imaging of the liver. Kaku Igaku (1992) 29, 85-95 (in Japanese).
5. Kudo M, Todo A, Ikekubo K and Hino M: Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage. Am J Gastoenterol (1992) 87, 865-870.
6. Liver Cancer Study Group of Japan: The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 3rd Ed, Kanehara Publishing Co., Tokyo (1992) (in Japanese).
7. Koizumi K, Uchiyama G, Arai T, Ainoda T and Yoda Y: A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: Evaluation of the validity of several functional parameters. Ann Nucl Med (1992) 6, 83-87.
8. Vera DR, Krohn KA, Stadalnik RC and Scheibe PO: Tc-99m-galactosyl-neoglycoalbumin: In vivo characterization of receptor-mediated binding to hepatocytes. Radiology (1984) 151, 191-196.
9. Bossuyt A, DeGeeter F, Jacobs A, Camus M and Thornback JR: Initial clinical experience with a new kit formulation of Tc-99m-β galactosylated albumin for functional hepatic imaging. Nucl Med Commu (1990) 11, 469-475.
10. Ha-Kawa SK and Tanaka Y: A quantitative model of technetium-99m-DTPA-galactocyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med (1991) 32, 2233-2240.
11. 99mTc-galactosyl serum albumin. Kaku Igaku (1993) 30, 1333-1339 (in Japanese).
12. 99mTc-GSA scintigraphy: Interobserver variation and intraobserver variation. Kaku Igaku (1996) 33, 1-7 (in Japanese).
13. 99mTc-GSA. Kaku Igaku (1996) 33, 935-942 (in Japanese).
14. Okazaki M: Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. Nihon Shokaki Geka Gakkai Zasshi (1995) 28, 1878-1882 (in Japanese).
15. Sakaguchi H, Uchida H, Matsuo N, Sakaguchi S, Anai H, Makutani S, Yoshioka T and Ohishi H: Transcatheter arterial chemoembolization for hepatocellular carcinoma: Indication and therapeutic results. Gastroenterology (Tokyo) (1997) 24, 205-212 (in Japanese).
16. Uchida H, Matsuo N, Sakaguchi H, Nagano N, Nishimine K and Ohishi H: Segmental embolotherapy for hepatic cancer: Keys to success. Cardiovasc Intervent Radiol (1993) 16, 67-71.
17. Kanno T, Kim K, Kurioka N, Shiomi S, Saito S, Kuroki T, Harihara S, Kobayashi K, Monna T, Kobayashi N, Nakatsuka H and Yamamoto S: Quantification analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Nippon Shokakibyo Gakkai Zasshi (1986) 83, 1483-1488 (in Japanese).
18. Nakao N, Miura K, Takayasu Y, Wada Y, Takahashi H, Hayashi T and Miura T: Indication of transcatheter arterial embolization in hepatocellular carcinoma with liver cirrhosis evaluated from the liver function tests. Nippon Shokakibyo Gakkai Zasshi (1984) 81, 1995-1999 (in Japanese).
19. Yumoto Y, Umeda M, Ohshima K, Ogawa H, Kurokawa T, Kajitani M, Yumoto E, Hanafusa T, Tsuboi H, Higashi T, Mitani T and Tsuji T: Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin. Cancer Chemother Pharmacol (1994) 33, S1-6.
20. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y and Tanaka Y: Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery (1995) 117, 429-434.
21. 99mTc-GSA in patients with chronic liver disease and/or hepatocellular carcinoma before and after transcatheter arterial embolization. Kaku Igaku (1991) 28, 1385-1392 (in Japanese).
22. 99mTc-GSA dynamic SPECT before and after chemolipiodolization in patients with hepatocellular carcinoma. Ann Nucl Med (1998) 12, 369-373.
23. Yamanaka N, Okamoto E, Kuwata K and Tanaka N: A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg (1984) 200, 658-663.
24. Shijo H, Okazaki M, Higashihara H, Koganemaru F and Okumura M: Hepatocellular carcinoma: A multivariate analysis of prognositic features in patients treated with hepatic arterial embolization. Am J Gastroenterol (1992) 87, 1154-1159.
25. Kudo M, Vera DR, Stadalnik RC, Trudeau WL, Ikekubo K and Todo A: In vivo measurement of hepatic binding protein in chronic liver disease: Validation as a measure of hepatic functional reserve. Nippon Shokakibyo Gakkai Zasshi (1991) 88, 40-50 (in Japanese).
26. 99mTc-GSA: Effect of hyperbilirubinemia and usefulness of regional reserved hepatic functional imaging. Kaku Igaku (1996) 33, 161-168 (in Japanese).
27. Sawamura T, Kawasato S, Tsuda M, Naitoh Y, Shiozaki Y and Sameshima Y: Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma. Gastroenterol Jpn (1985) 20, 201-208.
28. Stockert RJ and Becker FF: Diminished hepatic binding protein for desialylated glycoproteins during chemical hepatocarcinogenesis. Cancer Res (1980) 40, 3632-3634.